The HELLP-syndrome; maternal-fetal outcome and follow up of infants

J Perinat Med. 2003;31(3):201-8. doi: 10.1515/JPM.2003.027.

Abstract

Objective: To investigate maternal-fetal outcome of infants born after pregnancies complicated by (H)ELLP syndrome.

Study design: A retrospective cohort study was performed on patients with the HELLP or ELLP syndrome. Maternal and perinatal complications were recorded. The follow-up period of the infants was at least 18 months. A multivariate regression analysis was done to define the variables mostly contributing to adverse outcome.

Results: No maternal deaths occurred. Eighteen infants of the HELLP group and six infants of the ELLP group died; total perinatal mortality was 17.6%. After 18 months four infants had major handicaps, making a total adverse outcome of 22.8%. Statistical analysis shows early gestational age, prolongation of pregnancy and administration of antihypertensive medication as the factors influencing outcome of the infants most.

Conclusions: Prolongation of pregnancy contributed to better perinatal outcome, while administration of antihypertensive medication and early gestational age were related to a more unfavorable outcome.

MeSH terms

  • Abruptio Placentae / complications
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use
  • Bronchopulmonary Dysplasia / epidemiology
  • Cohort Studies
  • Disabled Children
  • Eclampsia / complications
  • Female
  • Follow-Up Studies
  • Gestational Age
  • HELLP Syndrome / complications*
  • HELLP Syndrome / therapy
  • Hemiplegia / epidemiology
  • Humans
  • Infant Mortality
  • Infant, Newborn
  • Male
  • Pregnancy
  • Pregnancy Outcome*
  • Prenatal Exposure Delayed Effects*
  • Prognosis
  • Regression Analysis
  • Respiration, Artificial
  • Respiratory Distress Syndrome, Newborn / epidemiology
  • Respiratory Distress Syndrome, Newborn / therapy
  • Retrospective Studies

Substances

  • Antihypertensive Agents